The healthcare industry, as a whole, has always been on an upward curve, because wellness is paramount for humanity. The prosperity of the healthcare industry can also be credited to its pursuit of excellence, evolving continuously and adopting the next technology that can yield better medical results. In the past decade, single-use bioprocessing systems have emerged as a viable alternative to reusable bioprocessing systems when it comes to media preparation and storage, cell harvesting fermentation, buffer preparation, and purification. On the back of increased investment on clinical research by various private and public bodies, the market for single-use bioprocessing systems is flourishing.

According to this business intelligence report, the demand in the global single-use bioprocessing systems market will expand at an impressive CAGR of 11.3% during the forecast period of 2017 to 2024. Revenue-wise, total opportunities in this market are estimated to attain a valuation of US$5,914.6 million by the end of 2024, mounting-up from its evaluated worth of US$2,791.4 million as of 2017. The report has also emphasized on examining the lucrativeness of the North America single-use bioprocessing systems market, which is estimated to be worth US$1,596.4 million by 2024, with the regional demand multiplying at a CAGR of 11.3% during 2017 to 2024.

Some of the key factors primed to drive the single-use bioprocessing systems market are: customization of products as per the need of consumers, benefits of overall reduction in costs and processing time, growth in the production of monoclonal antibodies, and rise in contract manufacturing and outsourcing activities in the biopharmaceutical industry. On the other hand, technical difficulties pertaining to large-scale bio-production and disposal are a few restraints curtailing the progress of this market. The trend of R&D outsourcing is expected to open new opportunities in this market.

Bags, Bioreactors, and Fermenters Leading Product Segments

Product-wise, this report segments the single-use bioprocessing systems market into bioreactors and fermenters, bags, bioprocess containers, mixers, filtration devices, tubing, connectors and clamps, sampling systems, and probes and sensors. Among these, bags and bioreactors and fermenters have been identified as the two product segments with maximum demand. While the single-use processing bags segment is estimated to generate a revenue of 1,595.2 million by the end of 2024, the opportunities in the single-use bioreactors and fermenters market is projected to attain a valuation of US$1,237.7 million by 2024.

Robust growth of bioprocessing bags is due to repeat purchases for several upstream and downstream functions such as mixing, filtration, storage, transport, and media preparation and fermentation. Acceptability in wide applications and ability to be customized according to user requirements is likely to augment the segment during the forecast period. On the other hand, strong growth of the bioreactors and fermenters segment can be attributed to several factors such as the expansion of R&D facilities of major pharmaceutical organizations, higher adoption of single-use technologies by CMOs and CROs producing biologics, and rise in consumer awareness about the benefits of single-use bioreactors.

Monoclonal Antibody Production Key Application Segment

Application-wise, the single-use bioprocessing products market has been classified into monoclonal antibody production, vaccine production, patient specific cell therapies, plant cell cultivation, and others. Monoclonal antibody production has been detected as the key application segment of the market, promising to provide for a demand worth of US$3,904.8 mn by the end of 2024, which will be nearly two-third of the overall demand.

Based on end-users, the market for single-use bioprocessing systems has been bifurcated into pharmaceutical, contract research and contract manufacturing organizations (CROs and CMOs), biotechnology, and academic and research institutes. The first three end-users have been identified as the most profitable ones, and in that order.

Europe Most Profitable Region by a Slender Marginal

Out of the five regions evaluated for their potential of demand for single-use bioprocessing systems, viz. Europe, North America, Asia Pacific, the Middle East and Africa, and Latin America, the first three have been highlighted as the key regions. Driven by a larger consumer base that is making the transition from stainless steel to single-use set-ups in their manufacturing facilities, the Europe single-use bioprocessing systems market is estimated to be worth US$1,680.0 million by the end of 2024. On the other hand, the demand from the region of Asia Pacific is primed to expand at the strongest CAGR of 12.6% during the period of 2017 to 2024. Mushrooming of biotech start-ups and greater influx of contract manufacturers in the emerging economies of India and China is driving the APAC single-use bioprocessing systems market.

Bioprocessing is a significant part of biopharmaceutical development and production processes and single-use bioprocessing systems, which are meant for one-time use, have recently found their unique position in the biopharmaceutical and biotherapeutics industry. Biomanufacturing facilities which once housed only stainless steel equipment are paving the way for a hybrid setup which also incorporates single-use technologies. New facilities manufacturing biologics, especially CRO’s/CMO’s and small biotechnology startups are increasingly opting for fully single-use plants. These systems have made the production of clinical trial drugs as well as commercially manufactured drugs cost-effective and flexible. The market for single-use bioprocessing systems is expected to grow at a double-digit figure during the forecast period from 2017 to 2024 and shall be driven by factors such as lowered labor efforts, lowered capital cost, and riddance of time, money, and efforts spent on sterilization procedures.

Single-use Bioprocessing Systems Market: Scope and Methodology

This report on the global single-use bioprocessing systems market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Detailed qualitative analysis of factors responsible for driving and restraining market growth and opportunities has been provided in the market overview section. Market revenue in terms of US$ Million for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2017 to 2024 are provided for all the segments, considering 2016 as the base year.

Market related factors such as technological developments, product innovation, expansion of infrastructural facilities by major and small pharmaceuticals, and historical year-on-year growth have been taken into consideration while estimating the market size. Growth rates for each segment within the global single-use bioprocessing systems market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, drug development life cycle, and regulatory requirements. These factors would help the market players to take strategic decisions in order to strengthen their positions and expand their share in the global market.

Single-use Bioprocessing Systems Market: Segmentation

Based on product type, the global single-use bioprocessing systems market has been segmented into bioreactors and fermenters, mixers, bags, filtration devices, tubing, sampling systems, connectors & clamps, and sensors & probes. Bags and bioreactors are the most prominently selling products in the single-use bioprocessing systems market.

Geographically, the global single-use bioprocessing systems market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been further segmented by major countries. A global overview has been provided, and the North America region has been analyzed in depth at country as well as product, application, and end-user segment level. The countries in North America section include the U.S. and Canada. The regions of Europe, Asia Pacific, Latin America, and Middle East & Africa have been briefly profiled at country level. The countries include the U.K., Germany, France, Italy, China, Japan, Australia & New Zealand, Brazil, Mexico, the UAE, and South Africa.

Single-use Bioprocessing Systems Market: Competitive Landscape

The competition matrix section included in the report is likely to assist the existing players to increase their market shares and new companies to establish their presence in the single-use bioprocessing systems market. The report also profiles major players in the single-use bioprocessing systems market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Thermo Fisher Scientific, Merck KGaA (Merck Millipore), Danaher Corporation (Pall Corporation), Sartorius AG, Eppendorf AG, GE Healthcare, PBS Biotech, Inc., Meissner Filtration Products, Finesse Solutions, Sentinel Process Solutions, and Saint-Gobain.

The global single-use bioprocessing systems market has been segmented as follows: